You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials

 

Online download statistics by month:

Online download statistics by month: May 2022 to September 2025

AbstractFullPdf
May 2022588594144
Jun 2022417425137
Jul 202224424672
Aug 202217117424
Sep 202216516917
Oct 202219219215
Nov 202214214221
Dec 202210410420
Jan 202319219329
Feb 202312412741
Mar 202310510520
Apr 2023777723
May 202313313523
Jun 202310210316
Jul 2023636416
Aug 202311311321
Sep 2023696923
Oct 202312012029
Nov 2023878822
Dec 2023838432
Jan 2024787825
Feb 2024717131
Mar 202411411745
Apr 202410010042
May 2024626426
Jun 2024575625
Jul 2024636424
Aug 2024818052
Sep 2024646632
Oct 2024727231
Nov 2024717231
Dec 2024828335
Jan 2025515127
Feb 202512512526
Mar 2025646426
Apr 2025565632
May 2025757633
Jun 2025303014
Jul 2025110
Sep 2025110
Total460946511302